Search for: "Ortho-McNeil, Inc." Results 101 - 120 of 209
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jul 2010, 1:05 am by Kelly
Biogaran and Laboratoires Medidom (EPLAW) Fortical (Calcitonin) – US: Unigene secures ruling of infringement against Apotex in Fortical patent suit (Patent Docs) Levaquin (Levofloxacin) – US: Federal Circuit denies rehearing petition in Levaquin Patent Term Extension case: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
19 Jul 2010, 1:12 pm by FDABlog HPM
’s (“Lupin’s”) Petition for Rehearing en banc of a May 10, 2010 panel decision in Ortho-McNeil Pharmaceutical, Inc. v. [read post]
15 Jul 2010, 10:39 pm by Carey, Danis & Lowe, L.L.C.
Texas resident Kenneth Edward Adams has filed the newest lawsuit against Levaquin makers Johnson & Johnson, Ortho-McNeil Pharmaceutical Inc. and Johnson & Johnson Pharmaceutical Research and Development as of June 29 of 2010. [read post]
14 Jul 2010, 6:47 pm by Kelly
Glaxo tries a ‘Linux’ (Spicy IP) TB Alliance and DNDi team up to fight neglected diseases (IP Watch) Australia: Pharmaceuticals extensions and international inequities: H Lundbeck A/S v Alphapharm Pty Ltd, Ortho-McNeil Pharmaceutical, Inc v Lupin Pharmaceuticals, Inc (Patentology) Australia: The ‘morality’ of gene patents (Patentology) Belgium: Antwerp commercial court finds Belgian counterpart of EU patent covering process for producing… [read post]
28 Jun 2010, 3:50 am by Steve McConnell
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2181 (Phila. [read post]
22 Jun 2010, 9:45 pm by Patent Docs
Kappos and Ortho-McNeil Pharmaceutical, Inc. v. [read post]
8 Jun 2010, 11:05 pm
" Ortho-McNeil Pharm., Inc. v. [read post]
28 May 2010, 9:30 am by admin
May 10, 2010) (80 PTCJ 56, 5/14/10), and Ortho-McNeil Pharmaceutical Inc. v. [read post]
27 May 2010, 3:20 am
(Patent Docs) Levaquin (Levofloxacin) – US: When it comes to patent term extensions, an enantiomer is a different drug from racemate: Ortho-McNeil Pharma v. [read post]
25 May 2010, 7:54 am by Ed Wallis
” As a result, “Ortho-McNeil Pharmaceutical LLC will pay a $6.14 million criminal fine after pleading guilty…to one count of misdemeanor violation of the Food, Drug and Cosmetic Act for promoting Topamax for unproved uses,” while “its holding company, Titusville, NJ-based Ortho-McNeil-Janssen Pharmaceuticals Inc., will pay $75.37 million to resolve civil allegations under the False Claims Act. [read post]
18 May 2010, 7:03 pm by Carey, Danis & Lowe
The agreement also mandates a centralized system that tracks all presentation engagements by Ortho-McNeil personnel. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Levaquin (Levofloxacin) - US: CAFC upholds patent term extensions in Levaquin and Metvixia cases: Ortho-McNeil and Daiichi Sankyo v. [read post]
13 May 2010, 4:57 pm by mcarzima@imediainc.com
Two subsidiaries of Johnson & Johnson, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc., have agreed to pay more than $81 million to settle allegations that they violated the False Claims Act by illegally promoting the epilepsy drug, Topomax. [read post]
11 May 2010, 7:07 pm by Carey, Danis & Lowe, L.L.C.
The suit names Johnson & Johnson, Ortho-McNeil Pharmaceuticals Inc. and Johnson & Johnson Pharmaceutical Research and Development LLC as defendants to Presley's claim. [read post]